查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1486844

下腔靜脈過濾器 (IVCF) 的全球市場 - 市場分析、競爭格局、市場預測 (2030)

Inferior Vena Cava Filters (IVCF) - Market Insights, Competitive Landscape and Market Forecast-2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

預計 2024 年至 2030 年預測期內，全球下腔靜脈過濾器 (IVCF) 市場規模將以 5.67% 的複合年增長率成長。下腔靜脈濾器（IVCF）的需求主要是由於肺栓塞和靜脈血栓栓塞盛行率的增加而推動的。此外，由於主要國家在產品開發、技術進步和設備批准方面的許多持續改進，促進了下腔靜脈市場的整體成長，預計該市場將會成長。這些是2024-2030年預測期內下腔靜脈市場積極成長的關鍵驅動因素。

下腔靜脈濾器（IVCF）市場動態

下腔靜脈濾器（IVCF）在預防肺栓塞和靜脈血栓栓塞方面發揮重要作用。根據澳洲政府衛生和老年護理部的研究 (2021)，靜脈血栓栓塞 (VTE) 對健康構成重大威脅。肺栓塞每年影響超過 17,000 名澳洲人，隨著人口老化，肺栓塞的發生率也隨之增加。

此外，根據國家藥物圖書館（NIH）（2020）進行的 "急診室隊列中肺栓塞盛行率：依研究國家進行的系統性回顧和薈萃分析" 研究，肺栓塞盛行率為 23歐洲為%，北美為8%。因此，這些統計數據和數據預計將增加下腔靜脈過濾器 (IVCF) 的未來使用並推動未來市場。

此外，主要產業參與者不斷增加的器械批准也在推動下腔靜脈過濾器 (IVCF) 未來整體市場的發展中發揮著重要作用。 2022年12月，可回收式下腔靜脈過濾器（IVCF）ZYLOX Octoplus TM 獲得中國國家藥品監督管理局（NMPA）批准。此過濾器主要用於預防週邊血管深部靜脈血栓（DVT）引起的肺栓塞（PE）。隨著這些知名製造商的 IVCF 產品獲得監管部門的批准，醫療保健提供者渴望將這種先進的解決方案納入他們的治療方案中。他們的興趣在於改善患者的治療效果並最大限度地降低與靜脈血栓栓塞相關的風險。

此外，2024 年 1 月，Cook Medical 的 Celect Platinum 腔靜脈過濾器和 Gunther Tulip 腔靜脈過濾器獲得 FDA 批准。與先前的過濾器型號相比，Celect 腔靜脈過濾器的特點是靈活性更高且易於插入。此外，我們的復健率高達90%以上，為成功復健提供了進一步的保證。因此，最近對下腔靜脈過濾器（IVCF）的批准和需求的增加反映了下腔靜脈過濾器（IVCF）的未來市場成長。

但是，有以下問題的風險：下腔靜脈過濾器 (IVCF) 從其原始位置遷移、過濾器損壞、過濾器上出現孔、過濾器內形成血塊以及回收問題，可能會抑制下腔靜脈過濾器（IVCF）的市場需求。

下腔靜脈濾器（IVCF）市場細分分析

下腔靜脈過濾器 (IVCF) 市場產品細分，可回收下腔靜脈過濾器 (IVCF) 類別預計將在 2023 年佔據下腔靜脈過濾器 (IVCF) 市場的主要收入佔有率。這可能是由於可回收下腔靜脈過濾器 (IVCF) 提供的各種好處和應用。

本報告研究和分析了全球下腔靜脈過濾器 (IVCF) 市場，提供市場規模和預測、驅動因素和課題、公司和產品概況等。

目錄

第一章下腔靜脈過濾器 (IVCF) 市場報告簡介

第二章下腔靜脈濾器（IVCF）市場執行摘要

  • 市場概覽

第三章競爭態勢

第 4 章監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第五章下腔靜脈濾網（IVCF）市場主要因素分析

  • 下腔靜脈濾網 (IVCF) 市場驅動因素
  • 下腔靜脈濾器 (IVCF) 市場的限制與課題
  • 下腔靜脈濾網 (IVCF) 市場機會

第 6 章波特下腔靜脈濾器 (IVCF) 市場五力分析

第七章下腔靜脈濾器（IVCF）市場評估

  • 依產品類型
    • 可回收下腔靜脈濾網 (IVCF)
    • 永久性下腔靜脈濾網 (IVCF)
  • 依材質
    • 非鐵磁性材料
    • 鐵磁性材料
  • 依用途
    • 靜脈血栓栓塞治療
    • 預防肺栓塞
  • 依最終用戶
    • 醫院
    • 手術中心
    • 其他
  • 地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他領域

第 8 章下腔靜脈濾器 (IVCF) 市場公司與產品概況

  • Cook
  • Radcliffe Medical Media.
  • Teleflex Incorporated.
  • Merit Medical Systems, Inc.
  • Cardinal Health, Inc.
  • Argon Medical Devices, Inc.
  • BD
  • Medtronic
  • Abbott Laboratories
  • Terumo Corporation
  • Johnson & Johnson Services, Inc.
  • Boston Scientific Corporation
  • Cordis.
  • C.R. Bard, Inc.
  • Mermaid Medical
  • LifeTech Scientific Corporation
  • Argon Medical Devices.
  • Masimo.
  • B. Braun Interventional Systems Inc.
  • Braile Biomdica

第9章KOL瀏覽量

第 10 章關於 DelveInsight

第 11 章免責聲明，聯絡我們

Product Code: DIMDCL0434

Inferior Vena Cava Filters Market By Product Type (Retrievable Inferior Vena Cava Filters, Permanent Inferior Vena Cava Filters), Material (Non-Ferromagnetic Material, Ferromagnetic Materials), Application (Venous Thromboembolism, Pulmonary Embolism), End User (Hospitals, Ambulatory Surgical Centers, And Others), And Geography (North America, Europe, Asia-Pacific, And Rest Of The World) is expected to grow at a steady cagr forecast till 2030 owing to the growing incidence of pulmonary embolism, venous thromboembolism (vte) and technological advancement with increasing approvals of device from leading countries across the globe.

The global Inferior Vena Cava Filters Market is estimated to grow at a CAGR of 5.67% during the forecast period from 2024 to 2030. The demand for Inferior Vena Cava Filters is primarily being boosted by the growing incidence of pulmonary embolism and venous thromboembolism. Furthermore, the inferior vena cava filter market is anticipated to grow on account of a large number of ongoing improvements in product development, technological advancement, and approvals of device from leading countries contributing to the overall growth of the inferior vena cava market. These are some of the major drivers that are responsible in contributing to the positive growth of the inferior vena cava market during the forecast period from 2024-2030.

Inferior Vena Cava Filters Market Dynamics:

The inferior vena cava filters (IVCF) plays an important role in the prevention of pulmonary embolism and venous thromboembolism. According to the study of Australian Government Department of Health and Aged Care (2021), venous thromboembolism (VTE) poses a significant threat to health. Annually, over 17,000 Australians will have pulmonary embolism every year, and the incidence increases in the aging population.

Furthermore, the study conducted under National Library of Medicines (NIH) 2020, "Pulmonary embolism prevalence among emergency department cohorts: A systematic review and meta-analysis by country of study", stated that the prevalence of pulmonary embolism in Europe was 23% and in North America was 8%. As a result these statistics and data are expected to increase the future use of inferior vena cava filters thus fueling the future market of the Inferior Vena Cava Filters.

Additionally, the increasing approvals of devices from leading industries companies are also playing the major role in boosting the overall future market of inferior vena cava filters. In December 2022, Retrievable Inferior Vena Cava Filter-ZYLOX OctoplusTM received approval from China's National Medical Products Administration (NMPA). This filter, is designed to prevent pulmonary embolism (PE) mainly caused by deep vein thrombosis (DVT) in the peripheral vasculature. Thus, with prominent manufacturers obtaining regulatory clearance for IVCF products, healthcare providers are keen to incorporate these advanced solutions into their treatment protocols. Their focus lies on improving patient outcomes and minimizing the risks associated with venous thromboembolism.

Additionally, In January, 2024 Cook Medical received FDA clearance for its Celect Platinum Vena Cava filter and Gunther Tulip Vena Cava Filter. The Celect Vena Cava Filter stands out for its enhanced flexibility and ease of insertion compared to earlier filter models. Additionally, boasting a retrieval rate exceeding 90%, it offers added assurance in terms of retrieval success. Thus the recent approvals and growing demand of inferior vena cava filters are reflecting the future market growth of inferior vena cava filters.

However, the risk of complication such as movement of IVCF from its original site, filter fracture, filter perforation or the blood clot formation within the filter and issues related with retrieval may hinder the market demand of Inferior Vena Cava Filters.

Inferior Vena Cava Filters Market Segment Analysis:

Inferior Vena Cava Filters Market By Product Type (Retrievable Inferior Vena Cava Filters, Permanent Inferior Vena Cava Filters), Material (Non-Ferromagnetic Material, Ferromagnetic Materials), Application (Treatment Of Venous Thromboembolism, Prevention Of Pulmonary Embolism), End-User (Hospitals, Surgical Centers, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest Of The World)

In the product segment of the Inferior Vena Cava Filters market, the Retrievable Inferior Vena Cava Filters category is estimated to mass a significant revenue share in the Inferior Vena Cava Filters Market in 2023. This can be attributed to the various advantages and applications provided by the Retrievable Inferior Vena Cava Filters. Inferior vena cava (IVC) filters are medical devices which helps in preventing blood clots from traveling to the lungs, which can cause a condition known as pulmonary embolism. These filters are typically implanted in the inferior vena cava, the large vein that carries deoxygenated blood from the lower body to the heart. Pulmonary embolism (PE) is a serious medical condition which is characterized by the sudden blockage of one or more arteries in the lungs by blood clots. These clots usually originate in the deep veins of the legs, a condition known as deep vein thrombosis (DVT), and then travel through the bloodstream to the lungs.

These filters can be removed once the risk of pulmonary embolism has passed. They are often used for temporary protection against pulmonary embolism making patients suitable who only require short-term prophylaxis, such as those undergoing high-risk surgeries or trauma. Besides this the Retrievable filters offer flexibility such as if the risk of pulmonary embolism decreases or resolves, the filter can be safely removed. Additionally, removing a retrievable filter once it is no longer needed reduces the risk of long-term complications associated with permanent filter placement. The retrieval procedure for retrievable filters is typically less invasive than the initial placement procedure. It often involves a simple catheter-based technique, performed under fluoroscopic guidance, and can be done on an outpatient basis. Hence all the factors and advancement in technology are promoting the overall market size of Inferior Vena Cava Filter during the forecast period as the patients who require temporary protection against pulmonary embolism, the ability to have the filter removed once the risk has passed can improve overall comfort and quality of life.

North America Is Expected To Dominate The Overall Inferior Vena Cava Market:

North America is expected to account for the highest proportion of the Inferior Vena Cava Filters Market in 2023, out of all regions. This is due to the presence of a large patient pool suffering from incidence of pulmonary embolism and venous thromboembolism. DVT is the most common cause of pulmonary embolism. According to the latest data provided by the American Lung Association (2023), in the United States the annual incidence of pulmonary embolism is around 900,000 every year.

Additionally, as per the latest data provided by the American Lung Association (2023), approximately 33% of individuals who have had a deep vein thrombosis or pulmonary embolism will face a recurrence of pulmonary embolism within a decade. Hence, these statistics and data are expected to increase the future use of inferior vena cava filters thus fuelling the future market of the Inferior Vena Cava Filters in North America.

Additionally, leading companies in the inferior vena cava filter market are prioritizing partnership agreements to expand their distribution networks and improve customer satisfaction. By forging strategic alliances, these companies aim to broaden their market reach and deliver enhanced value to their customer base. For instance, in June 2022, Cordis-X a US- based manufacturer announced the investment in Adient Medical, a US based manufacturer of next generation IVC filter that provide protection against pulmonary embolism. Through this partnership, Cordis aims to expand its product further with solutions that meet unmet needs in cardiovascular health.

Furthermore, in North America individuals undergoing major surgery (e.g., orthopaedic surgery), trauma patients, and those with contraindications to anticoagulant therapy require IVC filters as these filters play a crucial role in the prevention and management of VTE in North America.

Inferior Vena Cava Filters Market Key Players:

Some of the key market players operating in the Inferior Vena Cava Filters include Cook, Radcliffe Medical Media., Teleflex Incorporated, Merit Medical Systems, Inc., Cardinal Health, Inc., Argon Medical Devices, Inc., BD, Medtronic, Abbott Laboratories, Terumo Corporation, Johnson & Johnson Services, Inc., Boston Scientific Corporation, Cordis., C.R. Bard, Inc., Mermaid Medical, LifeTech Scientific Corporation, Argon Medical Devices., Masimo., B. Braun Interventional Systems Inc., Braile Biomdica.

Recent Developmental Activities In The Inferior Vena Cava Filters Market:

  • In December 2021, Philips CavaClear Laser Sheath, the first laser-based device authorized by the U.S. Food and Drug Administration for marketing, targets the removal of Inferior Vena Cava (IVC) filters. This innovative device is specifically designed in utilizing laser technology to ablate tissue and facilitate detachment.

Key Takeaways From The Inferior Vena Cava Filters Market Report Study

  • Market size analysis for current Inferior Vena Cava Filters Market size (2023), and market forecast for 6 years (2024-2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
  • Key companies dominating the global Inferior Vena Cava Filters market.
  • Various opportunities available for the other competitors in the Inferior Vena Cava Filters Market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current Inferior Vena Cava Filters market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for Inferior Vena Cava Filters market growth in the coming future?

Target Audience Who Can Be Benefited From This Inferior Vena Cava Filters Market Report Study

  • Inferior Vena Cava Filters product providers
  • Research organizations and consulting companies
  • Cardiac Restoration Systems-related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in Inferior Vena Cava Filters
  • Various end-users who want to know more about the Inferior Vena Cava Filters Market and the latest technological developments in the Inferior Vena Cava Filters Market.

Frequently Asked Questions For The Inferior Vena Cava Filters Market:

1. What are Inferior Vena Cava Filters?

Inferior vena cava (IVC) filters are medical devices which helps in preventing blood clots from traveling to the lungs, which can cause a condition known as pulmonary embolism. These filters are typically implanted in the inferior vena cava, the large vein that carries deoxygenated blood from the lower body to the heart.

2. What is the market for Inferior Vena Cava Filters?

The global Inferior Vena Cava Filters Market is estimated to grow at a CAGR of 5.67% during the forecast period from 2024 to 2030.

3. What are the drivers for the global Inferior Vena Cava Filters market?

The demand for Inferior Vena Cava Filters is primarily being boosted by the growing incidence of pulmonary embolism and venous thromboembolism. Furthermore, the inferior vena cava filter market is anticipated to grow on account of a large number of ongoing improvements in product development, technological advancement, and approvals of device from leading countries contributing to the overall growth of the inferior vena cava market. These are some of the major drivers that are responsible in contributing to the positive growth of the inferior vena cava market during the forecast period from 2024-2030.

4. Who are the key players operating in the global Inferior Vena Cava Filters market?

Some of the key market players operating in the Inferior Vena Cava Filters include Cook, Radcliffe Medical Media., Teleflex Incorporated, Merit Medical Systems, Inc., Cardinal Health, Inc., Argon Medical Devices, Inc., BD, Medtronic, Abbott Laboratories, Terumo Corporation, Johnson & Johnson Services, Inc., Boston Scientific Corporation, Cordis., C.R. Bard, Inc., Mermaid Medical, LifeTech Scientific Corporation, Argon Medical Devices., Masimo., B. Braun Interventional Systems Inc., Braile Biomdica.

5. Which region has the highest share in the global Inferior Vena Cava Filters market?

North America is expected to account for the highest proportion of the Inferior Vena Cava Filters Market in 2023, out of all regions. This is due to the presence of a large patient pool suffering from incidence of pulmonary embolism and venous thromboembolism.

Table of Contents

1. Inferior Vena Cava Filters Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Inferior Vena Cava Filters Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Inferior Vena Cava Filters Market Key Factors Analysis

  • 5.1. Inferior Vena Cava Filters Market Drivers
    • 5.1.1. Growing incidence of pulmonary embolism and venous thromboembolism.
    • 5.1.2. Technological advancement with increasing approvals of device from leading industry companies
  • 5.2. Inferior Vena Cava Filters Market Restraints and Challenges
    • 5.2.1. Complication such as movement of IVCF from its original site
    • 5.2.2. Issues related with retrieval
  • 5.3. Inferior Vena Cava Filters Market Opportunities
    • 5.3.1. Ongoing advancements in IVCF technology

6. Inferior Vena Cava Filters Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Inferior Vena Cava Filters Market Assessment

  • 7.1. By Product Type
    • 7.1.1. Retrievable Inferior Vena Cava Filters
    • 7.1.2. Permanent Inferior Vena Cava Filters
  • 7.2. By Material
    • 7.2.1. Non-Ferromagnetic Material
    • 7.2.2. Ferromagnetic Materials
  • 7.3. By Application
    • 7.3.1. Treatment Of Venous Thromboembolism
    • 7.3.2. Prevention Of Pulmonary Embolism
  • 7.4. By End-User
    • 7.4.1. Hospitals
    • 7.4.2. Surgical Centers
    • 7.4.3. Others
  • 7.5. By Geography
    • 7.5.1. North America
      • 7.5.1.1. United States Inferior Vena Cava Filters Market Size in USD million (2021-2030)
      • 7.5.1.2. Canada Inferior Vena Cava Filters Market Size in USD million (2021-2030)
      • 7.5.1.3. Mexico Inferior Vena Cava Filters Market Size in USD million (2021-2030)
    • 7.5.2. Europe
      • 7.5.2.1. France Inferior Vena Cava Filters Market Size in USD million (2021-2030)
      • 7.5.2.2. Germany Inferior Vena Cava Filters Market Size in USD million (2021-2030)
      • 7.5.2.3. United Kingdom Inferior Vena Cava Filters Market Size in USD million (2021-2030)
      • 7.5.2.4. Italy Inferior Vena Cava Filters Market Size in USD million (2021-2030)
      • 7.5.2.5. Spain Inferior Vena Cava Filters Market Size in USD million (2021-2030)
      • 7.5.2.6. Rest of Europe Inferior Vena Cava Filters Market Size in USD million (2021-2030)
    • 7.5.3. Asia-Pacific
      • 7.5.3.1. China Inferior Vena Cava Filters Market Size in USD million (2021-2030)
      • 7.5.3.2. Japan Inferior Vena Cava Filters Market Size in USD million (2021-2030)
      • 7.5.3.3. India Inferior Vena Cava Filters Market Size in USD million (2021-2030)
      • 7.5.3.4. Australia Inferior Vena Cava Filters Market Size in USD million (2021-2030)
      • 7.5.3.5. South Korea Inferior Vena Cava Filters Market Size in USD million (2021-2030)
      • 7.5.3.6. Rest of Asia-Pacific Inferior Vena Cava Filters Market Size in USD million (2021-2030)
    • 7.5.4. Rest of the World (RoW)
      • 7.5.4.1. Middle East Inferior Vena Cava Filters Market Size in USD million (2021-2030)
      • 7.5.4.2. Africa Inferior Vena Cava Filters Market Size in USD million (2021-2030)
      • 7.5.4.3. South America Inferior Vena Cava Filters Market Size in USD million (2021-2030)

8. Inferior Vena Cava Filters Market Company and Product Profiles

  • 8.1. Cook
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. Radcliffe Medical Media.
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. Teleflex Incorporated.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. Merit Medical Systems, Inc.
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Cardinal Health, Inc.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Argon Medical Devices, Inc.
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. BD
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Medtronic
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Abbott Laboratories
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Terumo Corporation
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. Johnson & Johnson Services, Inc.
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Boston Scientific Corporation
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Cordis.
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. C.R. Bard, Inc.
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Mermaid Medical
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. LifeTech Scientific Corporation
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Argon Medical Devices.
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Masimo.
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. B. Braun Interventional Systems Inc.
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. Braile Biomdica
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. About DelveInsight

11. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Inferior Vena Cava Filters Market in Global (2021-2030)
  • Table 3: Inferior Vena Cava Filters Market in Global by Product Type (2021-2030)
  • Table 4: Inferior Vena Cava Filters Market in Global by Material (2021-2030)
  • Table 5: Inferior Vena Cava Filters Market in Global by Application (2021-2030)
  • Table 6: Inferior Vena Cava Filters Market in Global by End-User (2021-2030)
  • Table 7: Inferior Vena Cava Filters Market in Global by Geography (2021-2030)
  • Table 8: Inferior Vena Cava Filters Market in North America (2021-2030)
  • Table 9: Inferior Vena Cava Filters Market in North America by Country (2021-2030)
  • Table 10: Inferior Vena Cava Filters Market in the United States (2021-2030)
  • Table 11: Inferior Vena Cava Filters Market in Canada (2021-2030)
  • Table 12: Inferior Vena Cava Filters Market in Mexico (2021-2030)
  • Table 13: Inferior Vena Cava Filters Market in Europe (2021-2030)
  • Table 14: Inferior Vena Cava Filters Market in Europe by Country (2021-2030)
  • Table 15: Inferior Vena Cava Filters Market in France (2021-2030)
  • Table 16: Inferior Vena Cava Filters Market in Germany (2021-2030)
  • Table 17: Inferior Vena Cava Filters Market in the United Kingdom (2021-2030)
  • Table 18: Inferior Vena Cava Filters Market in Italy (2021-2030)
  • Table 19: Inferior Vena Cava Filters Market in Spain (2021-2030)
  • Table 20: Inferior Vena Cava Filters Market in the Rest of Europe (2021-2030)
  • Table 21: Inferior Vena Cava Filters Market in Asia-Pacific (2021-2030)
  • Table 22: Inferior Vena Cava Filters Market in Asia-Pacific by Country (2021-2030)
  • Table 23: Inferior Vena Cava Filters Market in China (2021-2030)
  • Table 24: Inferior Vena Cava Filters Market in Japan (2021-2030)
  • Table 25: Inferior Vena Cava Filters Market in India (2021-2030)
  • Table 26: Inferior Vena Cava Filters Market in Australia (2021-2030)
  • Table 27: Inferior Vena Cava Filters Market in South Korea (2021-2030)
  • Table 28: Inferior Vena Cava Filters Market in Rest of Asia-Pacific (2021-2030)
  • Table 29: Inferior Vena Cava Filters Market in the Rest of the World (2021-2030)
  • Table 30: Inferior Vena Cava Filters Market in RoW by Region (2021-2030)
  • Table 31: Inferior Vena Cava Filters Market in the Middle East (2021-2030)
  • Table 32: Inferior Vena Cava Filters Market in Africa (2021-2030)
  • Table 33: Inferior Vena Cava Filters Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Inferior Vena Cava Filters Market in Global (2021-2030)
  • Figure 3: Inferior Vena Cava Filters Market in Global by Product Type (2021-2030)
  • Figure 4: Inferior Vena Cava Filters Market in Global by Material (2021-2030)
  • Figure 5: Inferior Vena Cava Filters Market in Global by Application (2021-2030)
  • Figure 6: Inferior Vena Cava Filters Market in Global by End-User (2021-2030)
  • Figure 7: Inferior Vena Cava Filters Market in Global by Geography (2021-2030)
  • Figure 8: Inferior Vena Cava Filters Market in North America (2021-2030)
  • Figure 9: Inferior Vena Cava Filters Market in North America by Country (2021-2030)
  • Figure 10: Inferior Vena Cava Filters Market in the United States (2021-2030)
  • Figure 11: Inferior Vena Cava Filters Market in Canada (2021-2030)
  • Figure 12: Inferior Vena Cava Filters Market in Mexico (2021-2030)
  • Figure 13: Inferior Vena Cava Filters Market in Europe (2021-2030)
  • Figure 14: Inferior Vena Cava Filters Market in Europe by Country (2021-2030)
  • Figure 15: Inferior Vena Cava Filters Market in France (2021-2030)
  • Figure 16: Inferior Vena Cava Filters Market in Germany (2021-2030)
  • Figure 17: Inferior Vena Cava Filters Market in the United Kingdom (2021-2030)
  • Figure 18: Inferior Vena Cava Filters Market in Italy (2021-2030)
  • Figure 19: Inferior Vena Cava Filters Market in Spain (2021-2030)
  • Figure 20: Inferior Vena Cava Filters Market in the Rest of Europe (2021-2030)
  • Figure 21: Inferior Vena Cava Filters Market in Asia-Pacific (2021-2030)
  • Figure 22: Inferior Vena Cava Filters Market in Asia-Pacific by Country (2021-2030)
  • Figure 23: Inferior Vena Cava Filters Market in China (2021-2030)
  • Figure 24: Inferior Vena Cava Filters Market in Japan (2021-2030)
  • Figure 25: Inferior Vena Cava Filters Market in India (2021-2030)
  • Figure 26: Inferior Vena Cava Filters Market in Australia (2021-2030)
  • Figure 27: Inferior Vena Cava Filters Market in South Korea (2021-2030)
  • Figure 28: Inferior Vena Cava Filters Market in Rest of Asia-Pacific (2021-2030)
  • Figure 29: Inferior Vena Cava Filters Market in the Rest of the World (2021-2030)
  • Figure 30: Inferior Vena Cava Filters Market in RoW by Region (2021-2030)
  • Figure 31: Inferior Vena Cava Filters Market in the Middle East (2021-2030)
  • Figure 32: Inferior Vena Cava Filters Market in Africa (2021-2030)
  • Figure 33: Inferior Vena Cava Filters Market in South America (2021-2030)
  • Figure 34: Market Drivers
  • Figure 35: Market Barriers
  • Figure 36: Marker Opportunities
  • Figure 37: PORTER'S Five Force Analysis